ZA925305B - Inhibition of non-CD4 midiated HIV infection. - Google Patents

Inhibition of non-CD4 midiated HIV infection.

Info

Publication number
ZA925305B
ZA925305B ZA925305A ZA925305A ZA925305B ZA 925305 B ZA925305 B ZA 925305B ZA 925305 A ZA925305 A ZA 925305A ZA 925305 A ZA925305 A ZA 925305A ZA 925305 B ZA925305 B ZA 925305B
Authority
ZA
South Africa
Prior art keywords
midiated
inhibition
hiv infection
hiv
infection
Prior art date
Application number
ZA925305A
Inventor
Benson M Curtis
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA925305B publication Critical patent/ZA925305B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
ZA925305A 1991-07-16 1992-07-16 Inhibition of non-CD4 midiated HIV infection. ZA925305B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73121491A 1991-07-16 1991-07-16

Publications (1)

Publication Number Publication Date
ZA925305B true ZA925305B (en) 1993-06-14

Family

ID=24938578

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925305A ZA925305B (en) 1991-07-16 1992-07-16 Inhibition of non-CD4 midiated HIV infection.

Country Status (7)

Country Link
AU (1) AU2373792A (en)
IE (1) IE922308A1 (en)
IL (1) IL102508A0 (en)
MX (1) MX9204131A (en)
PT (1) PT100694A (en)
WO (1) WO1993001820A2 (en)
ZA (1) ZA925305B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224073A1 (en) * 1995-06-09 1996-12-27 Francisco Veas Means for detecting and preventing hiv infection involving use of receptors or binding sites capable of interacting with gp120
FR2748483B1 (en) * 1996-05-07 1998-07-24 Orstom MEANS FOR THE FIGHT OR DIAGNOSIS OF HIV INFECTION
EP1046651A1 (en) 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition and method for modulating dendritic cell-T interaction
AUPQ278899A0 (en) * 1999-09-13 1999-10-07 Csl Limited Dendritic cell membrane protein cire
US7691591B2 (en) 2002-09-20 2010-04-06 Stichting Katholieke Universiteit Methods of identifying and isolating cells expressing DC-sign
WO2004026326A2 (en) 2002-09-20 2004-04-01 Stichting Katholieke Universiteit Antigen uptake receptor for candida albicans on dendritic cells
AU2003301804A1 (en) * 2002-11-05 2004-06-07 Institut National De La Sante Et De La Recherche Medicale Dc-sign blockers and their use for preventing or treating viral infections.
US7427469B2 (en) 2002-11-05 2008-09-23 Institut Pasteur Method of treating cytomegalovirus with DC-SIGN blockers
EP1699487A4 (en) 2003-12-15 2009-07-08 Alexion Pharma Inc Novel anti-dc-sign antibodies
US20060105063A1 (en) * 2004-11-18 2006-05-18 Kent Hann Synergic combination of compositions containing aloe vera isolates and their therapeutic application
GB0702183D0 (en) * 2007-02-05 2007-03-14 Iti Scotland Ltd Pathogen binding

Also Published As

Publication number Publication date
AU2373792A (en) 1993-02-23
IL102508A0 (en) 1993-01-14
WO1993001820A3 (en) 1993-05-27
MX9204131A (en) 1993-04-01
WO1993001820A2 (en) 1993-02-04
PT100694A (en) 1993-10-29
IE922308A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
AU641769B2 (en) Inhibitors of HIV reverse transcriptase
ZA929869B (en) Hiv protease inhibitors
AU2216292A (en) Inhibitors of hiv reverse transcriptase
AU2469092A (en) Anti-hiv (aids) agents
PH31249A (en) Inhibitors of hiv protease.
IL102428A0 (en) Inhibitors of hiv protease useful for the treatment of aids
HU9300032D0 (en) Phenyl-acetamide derivatives of hiv inhibiting effect
AU7973994A (en) Combination therapy for hiv infection
AU8693491A (en) Synergism of hiv reverse transcriptase inhibitors
PH31044A (en) Sanitary napkin.
ZA925305B (en) Inhibition of non-CD4 midiated HIV infection.
AU8900691A (en) Hiv marker/aids vaccine
FI923497A0 (en) EXTENSION OF RELEASE.
AU7131991A (en) Hiv protease inhibiting agents
ZA925023B (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU7677891A (en) Inhibition of disease associated with immunodeficiency virus infection
EP0789565A4 (en) Prevention of hiv infection
EP0649308A4 (en) Prevention of hemolysis.
AU663106B2 (en) Porphyrin-based anti-HIV drug
ZA96722B (en) Combination therapy for hiv infection
AU9179891A (en) Hiv reverse transcriptase vaccine
AU1662092A (en) Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
AU7845191A (en) Inhibitors of HIV reverse transcriptase
AU2414992A (en) Method of combatting hiv infections
EP0575500A4 (en) Hiv protease inhibitors